Excipients

Pharmaceutical excipients, which can be functional or inactive ingredients, work to enhance the medically relevant properties of the API. When used to promote ingredient qualities, excipients can be an asset for formulators to increase stability, bulk up the formulation, or enhance the therapeutic effects of the API. Below you can explore helpful resources including editorial coverage and webinars related to pharmaceutical excipients.

  • The Future of Bispecific Antibodies

    After years of research and development, the field of bispecific antibodies (BsAbs) is gaining momentum. More than a dozen bispecific antibodies have secured FDA approval. These new therapies have added much-needed therapeutic value to challenging disease states such as relapsed/refractory multiple myeloma. In 12 months, three distinct CD3-engaging... read more

  • Shifting Sands: From Sensitivity to Accuracy in Bioanalysis

    In recent years, regulatory focus has notably shifted from sensitivity to accuracy, underscoring a pivotal change in how we approach toxicological assessments. While sensitivity remains a critical requirement, our advancing understanding of toxicology has highlighted the crucial need for precise target analysis. This shift in focus is particularly ... read more

  • Driving Innovation in Antibody Therapeutics, From Basic Research to the Clinic

    Nearly 25 years after the first FDA-approved antibody-drug conjugate (ADC), the field of antibody therapeutics continues to evolve. Advances in antibody development and engineering, as well as transformative progress in our understanding of biological processes and disease etiology, have unlocked new possibilities. This, in turn, has fueled an ... read more
Page

  • Infographic: Seven Softgel Myths

    Softgels are a popular dose format among consumers thanks to their high swallowability and quick onset of action. Yet pharmaceutical developers may not even consider softgels. Why the disconnect? Here are seven popular misconceptions about softgels and the facts that disprove them. read more

  • eBook: Proven Applications Using Variable Pathlength Spectroscopy

    This eBook provides details and insight into using Slope Spectroscopy and the CTech™ SoloVPE® variable pathlength spectroscopy system. The SoloVPE® system provides a rapid, robust, and repeatable, non-disruptive concentration measurement method for proteins, plasmid DNA, and nucleic acid modalities. Articles in this eBook ... read more

  • Analyses of Antibody Drugs Using Inert Ultra High Performance Liquid Chromatography

    This article introduces analyses of monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) for quality control using an inert UHPLC system that is extremely resistant to mobile phases containing high salt concentrations. By suppressing the interaction between antibody drugs and stationary phase, the system delivered ... read more

  • Whitepaper: Key Considerations for Extracting Proteins from Recombinant Host Cells

    In the biopharmaceutical industry, quality is pivotal. For a final product to meet quality standards, quality must be built into the production process. Biopharmaceuticals, however, are made from biologically sourced materials, which are inherently variable. read more

  • Whitepaper: How to Develop an Efficient Drug Formulation Process

    Developing an efficient drug formulation development process requires expertise. Ascendia Pharmaceuticals, a leading specialty CDMO, has been recognized as a Partner of Choice by many drug companies because they have solved complex formulations for nearly a decade. Ascendia’s white paper details how to implement a drug discovery... read more
Page

Webinars

  • <<
  • >>